Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

Marion Delcroix, Gerd Staehler, Henning Gall, Ekkehard Grünig, Matthias Held, Michael Halank, Hans Klose, Anton Vonk-Noordegraaf, Stephan Rosenkranz, Joanna Pepke-Zaba, Christian F. Opitz, J. Simon R. Gibbs, Tobias J. Lange, Iraklis Tsangaris, Doerte Huscher, David Pittrow, Karen M. Olsson, Marius M. Hoeper

Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Journal Issue: November
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marion Delcroix, Gerd Staehler, Henning Gall, Ekkehard Grünig, Matthias Held, Michael Halank, Hans Klose, Anton Vonk-Noordegraaf, Stephan Rosenkranz, Joanna Pepke-Zaba, Christian F. Opitz, J. Simon R. Gibbs, Tobias J. Lange, Iraklis Tsangaris, Doerte Huscher, David Pittrow, Karen M. Olsson, Marius M. Hoeper. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients. Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival in medically treated chronic thromboembolic pulmonary hypertension patients
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004


Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 272-282
Year: 2015



Predictors of poor outcome in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012


Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012


Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005

Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009



Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011


Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160108
Year: 2017